Quintiles has entered a strategic partnership with four teaching health boards in Scotland as part of its Prime Site program to accelerate development of new and more effective medicines. The alliance aims to increase access to clinical trials for both patients and investigators, and accelerate the collection of safety and efficacy data of investigational therapies.   Quintiles will work with NHS Scotland’s four university-based academic research centers in Aberdeen, Dundee, Edinburgh and Glasgo...